
Anti-DEDAFAntibody
CatalogNo.:2227
Size:100ugIgGin200ulPBS,pH7.4,purifiedbyimmunoaffinitychromatography.
Celldeathsignalsaretransducedbydeathdomain-containingadaptermoleculesandmembersofthecaspasefamilyofproteases.Anovelproteinthatinteractswiththedeatheffectordomainofcapase-8andcaspase-10hasbeendesignatedDEDAFandisdedenticaltothetranscriptionalrepressorRYBP.DEDAFisexpressedinmultipletissuesandcelllinesandappearstobeinvolvedintheregulationofbothcytoplasmicandnucleareventsofapoptosis.
Antigen:Peptidecorrespondingtoaa215-229ofhumanDEDAF(accessionno.AF179286).
Thissequenceisidenticaltothatofmouse.
HostSpecies:Rabbit
StABIlizers:None
Preservatives:0.02%sodiumazide.
Thisantibodyrecognizeshuman,mouse,andratDEDAF(32kDa).
Forinvitroinvestigationaluseonly.Notforuseintherapeuticordiagnosticprocedures.
APPLICATIONSImmunoblotting:useat1ug/ml.
WesternblotanalysisofDEDAFexpressioninhumanA549(laneA),HepG2(laneB),andmouse3T3(laneC)celllysateswithDEDAFantibodyat1μg/ml.
Immunohistochemistry:useat10ug/ml.
ImmunohistochemicalstainingofDEDAFinmouselivertissuewithDEDAFantibodyat10μg/ml.
Thesearerecommendedconcentrations.Endusershoulddetermineoptimalconcentrationsfortheirapplications.
Positivecontrol:WholecelllysatefromA549orHepG2cells.
DiluteinPBSormediumwhichisidenticaltothatusedintheassaysystem.
Thisantibodyisstableforatleastone(1)yearat-20oC.Avoidmultiplefreeze-thawcycles.